165
Participants
Start Date
November 1, 2017
Primary Completion Date
August 10, 2018
Study Completion Date
August 10, 2018
Multi-level pregnancy test
Study participants will be instructed to perform a baseline MLPT immediately prior to administering the first dose of abortion medication and a second MLPT one week later to ascertain the follow-up hCG range. Any woman who obtains a stable or increasing hCG result, when comparing the baseline test result with the follow-up test result, will be instructed to contact safe2choose. Any woman who obtains a decrease in her hCG range, when comparing the baseline test result with the follow-up test result, will be informed that her abortion was a success and she is no longer pregnant.
Gynuity Health Projects, New York
safe2choose
UNKNOWN
Gynuity Health Projects
OTHER